Health Care & Life Sciences » Pharmaceuticals | Taisho Pharmaceutical Holdings Co. Ltd.

Taisho Pharmaceutical Holdings Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
159,404
169,625
206,458
201,275
249,712
358,467
Total Accounts Receivable
78,068
80,146
75,157
69,450
75,163
71,132
Inventories
27,120
27,308
26,638
27,499
26,843
29,516
Other Current Assets
16,453
12,002
11,417
10,718
10,426
10,663
Total Current Assets
281,045
289,081
319,670
308,946
362,146
469,781
Net Property, Plant & Equipment
103,580
100,366
98,950
97,282
93,716
91,283
Total Investments and Advances
279,934
319,326
291,803
320,009
302,091
203,694
Intangible Assets
48,777
45,244
38,863
34,372
31,116
24,302
Other Assets
7,439
8,460
1,894
3,826
4,722
23,355
Total Assets
728,442
768,092
759,049
771,222
800,157
821,782
ST Debt & Current Portion LT Debt
342
286
153
212
483
Accounts Payable
27,859
29,133
27,082
23,327
19,939
Income Tax Payable
11,517
3,254
5,746
5,774
8,614
Other Current Liabilities
36,332
31,557
33,665
28,784
31,282
Total Current Liabilities
76,050
64,230
66,646
58,097
60,318
Long-Term Debt
452
351
248
145
48
Provision for Risks & Charges
21,224
23,817
24,910
24,488
24,392
Deferred Taxes
6,722
13,921
8,464
9,347
11,131
Other Liabilities
4,394
6,916
7,785
7,272
6,587
Total Liabilities
116,509
114,850
115,922
106,132
108,838
Common Equity (Total)
600,263
640,056
629,249
649,938
675,231
Total Shareholders' Equity
600,263
640,056
629,249
649,938
675,231
Total Equity
611,933
653,242
643,127
665,088
691,318
Liabilities & Shareholders' Equity
728,442
768,092
759,049
771,220
800,156
Accumulated Minority Interest
11,670
13,186
13,878
15,150
16,087

About Taisho Pharmaceutical Holdings Co.

View Profile
Address
3-24-1 Takada
Tokyo Tokyo 170
Japan
Employees -
Website http://www.taisho-holdings.co.jp
Updated 07/08/2019
Taisho Pharmaceutical Holdings Co. Ltd. engages in the management and administration of its group companies that manufactures and sells over-the-counter (OTC) drugs, foods, and other goods, etc. It operates through the following segments: Self-Medication and Prescription Pharmaceutical. The Self-Medication segment conducts research and development (R&D), manufacturing and sale of over-the-counter drugs, quasi-drugs, food, and general medical and hygiene supplies.